NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









YiPSCELL

YiPSCELL

Private
SeoulHealthcare & Life Scienceshttp://yipscell.com/

Last Round

Grant

Jun 23, 2026

Est. Valuation

$44.78M

Total Funding Raised

$24.51M

Company Overview

YiPSCELL is a biotechnology company that develops induced pluripotent stem cell (iPSC)-derived therapies and disease modeling platforms for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

induced pluripotent stem celliPSCregenerative medicinecell therapyorganoiddisease modelingdrug screeningin vitro testinganimal testing alternativesstem cell researchbiotech R&Dcell line supplylab-grown tissuepreclinical researchdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

YiPSCELL Comparables

Compare YiPSCELL with similar companies based on industry and business-model similarity.

YiPSCELL comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cynata Therapeutics Limited
78%
SereNeuro Therapeutics
76%
Axol Bioscience
74%

YiPSCELL Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2026
GrantOct 31, 2023
VC RoundDec 1, 2022
Series AJun 9, 2021
Series AMay 1, 2021
Seed
Sep 1, 2020

YiPSCELL Investors

Notable investors and investment history

YiPSCELL investors
InvestorRounds
InterVestSeries A, VC Round
KOTECGrant
Premier PartnersSeries A, VC Round
HB InvestmentSeries A, Grant, VC Round
Government of South KoreaGrant
AJU IB InvestmentSeries A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2022

    $12.4M raised from Premier Partners and AJU IB Investment.

  • Sep 1, 2020

    $1.7M round led by Daewoong Pharmaceutical

YiPSCELL Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

YiPSCELL Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about YiPSCELL's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2017
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.